Liraglutide has been found to reduce RAGE levels and hinder the production of inflammatory cytokines such as IL-1, IL-6, IL-12 and TNF-a
These findings underscore the critical need for physicians to thoroughly assess patient history before prescribing GLP-1 RAs and highlight the urgent requirement for further prospective clinical trials to fully understand the implications of GLP-1 RA use on mental health in the obese patient population
[60] A variety of other central neuromodulators, including (but not limited to) other antidepressants, may be tried for symptoms like bloating and distention (and not only in the setting of gastroparesis, but also for disorders of gutbrain interaction, or DGBI)
Who do I recommend this combination for
Cell Metabolism, 27 (4), 740756
Currently, we do not serve Arkansas, Connecticut, and New Mexico